Name: transforming growth factor-beta in cancer therapy, volume ii: cancer treatment and therapy (en Inglés)
Price: 1387307.00 COP
Availability: InStock
Author: Heldin, C. -H ; Jakowlew, Sonia B.
ISBN: 9781617377365

portada transforming growth factor-beta in cancer therapy, volume ii: cancer treatment and therapy (en Inglés)

Formato

Libro Físico

Prefacio de

C. -H Heldin

Ilustrado por

Sonia B. Jakowlew

Editorial

Humana

Autor

Heldin, C. -H ; Jakowlew, Sonia B.

Año

2010

Idioma

Inglés

N° páginas

786

Encuadernación

Tapa Blanda

Dimensiones

25.4 x 17.8 x 4.1 cm

Peso

1.38 kg.

ISBN

1617377368

ISBN13

9781617377365

Categorías

Oncología
Farmacología
Biología celular | citología

transforming growth factor-beta in cancer therapy, volume ii: cancer treatment and therapy (en Inglés)

C. -H Heldin (Prefacio de) · Sonia B. Jakowlew (Ilustrado por) · Humana · Tapa Blanda

Libro Nuevo

$ 1.387.307

$ 2.134.318

Ahorras: $ 747.011

35% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 07 de Junio y el Viernes 21 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "transforming growth factor-beta in cancer therapy, volume ii: cancer treatment and therapy (en Inglés)"

Transforming Growth Factor-B in Cancer Therapy, Volume II: Cancer Treatment and Therapy The chapters in this volume confer an abundance of knowledge about the current state ofour understanding oftransforming growth factor-B (TGF-B) in cancer treatment and therapy. Unlike several more traditional positive polypeptide growth factors that stim- ulate cellular proliferation, the prototypical TGF-B is now known to inhibit the growth of most normal cell types, including those of epithelial and mesenchymal origin. However, there are examplesofcell types that can be stimulated by TGF-B under certain conditions. TGF-B also induces the accumulation of matrix molecules by stimulating their synthesis as well as inhibiting their degradation. Moreover, TGF-B induces apoptosis of certain cell types, thereby restricting their proliferation. OveractivityofTGF- has been linked to several diseases. For instance, the effect ofTGF- on matrix accumulation contributes to fibrotic conditions, like glomerulonephritis, lung fibrosis and liver cirrhosis (1). TGF- has a very complicated role in cancer that is only beginning to be understood.